Trillium Therapeutics

+$0.20 (+2.31%) Today

+$0.01 (+0.06%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TRIL and other stocks, options, and ETFs commission-free!

About TRIL

Trillium Therapeutics Inc. Common Shares, also called Trillium Therapeutics, is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer.

CEO

Jan Skvarka

Employees

—

Headquarters

Mississauga, Ontario

Founded

2004

TRIL Key Statistics

Market Cap

962.90M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.34M

High Today

$8.77

Low Today

$8.43

Open Price

$8.50

Volume

667.79K

52 Week High

$20.96

52 Week Low

$5.66

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

TRIL Earnings

-$1.07

-$0.22

$0.64

$1.49

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.90 per share

Actual

-$0.11 per share